Evidence map›Paper›PMID 42571265›Full record

ArticleJAAD international2026

Trends in severe cutaneous adverse drug reactions before, during, and after the COVID-19 pandemic: A retrospective multicenter study of 794 cases.

Suiting Ao, Qing Zhao, Pengcheng Huai, Lele Sun, Wenchao Li, Yanhong Sun, Xiaoqi Yang, Yonghu Sun, Hong Liu, Furen Zhang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Suiting AoDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Qing ZhaoDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Pengcheng HuaiDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Lele SunDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Wenchao LiDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Yanhong SunDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Xiaoqi YangDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Yonghu SunDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Hong LiuDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Furen ZhangDermatology Hospital of Shandong First Medical University, Jinan, Shandong Province, PR China.
Shandong Severe Cutaneous Adverse Reactions Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

combination therapycoronavirus disease-19infectionpandemicsevere cutaneous adverse drug reactions

Identifiers

PMID42571265
PMCPMC13451892

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.